The diagnosis of HRPC typically involves monitoring prostate-specific antigen (PSA) levels. A rising PSA level despite hormone therapy is a key indicator. Additional diagnostic tools may include imaging techniques like MRI, CT scans, and bone scans to assess the spread and growth of the cancer. Biopsies may also be performed to examine the cancer cells' characteristics and confirm the diagnosis.
